COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 1548: Articles 15471-15480  | Next

Clinical manifestations of hospitalized COVID-19 patients in Bangladesh: a 14-day observational study
Shaha, M., Islam, M. A., Huq, F., Roy, B., Kabir, A., Salimullah, M., Mahtab, M. A., Akbar, S. M. F.
10.1101/2021.04.27.21256018 — Posted: 2021-04-29
Optimal allocation of vaccines - the role of childrens vaccination
Gavish, N., Katriel, G.
10.1101/2021.04.26.21256101 — Posted: 2021-04-29
Race-ethnicity and Perceptional Determinants of COVID-19 Vaccination Intentions: A Cross-sectional Study Among Health Workers and the General Population in the San Francisco Bay Area
Weng, Y., Lu, D., Bollyky, J., Jain, V., Desai, M., Lindan, C., Boothroyd, D., Judson, T., Doernberg, S. B., Holubar, M., Sample, H., Huang, B., Maldonado, Y., Rutherford, G. W., Grumbach, K., the California Pandemic Consortium
10.1101/2021.04.26.21255893 — Posted: 2021-04-29
Real world evidence of calcifediol use and mortality rate of COVID-19 hospitalized in a large cohort of 16,401 Andalusian patients
Loucera, C., Pena-Chilet, M., Esteban-Medina, M., Munoyerro-Muniz, D., Villegas, R., Lopez-Miranda, J., Rodriguez-Bano, J., Tunez, I., Bouillon, R., Dopazo, J., Quesada Gomez, J. M.
10.1101/2021.04.27.21255937 — Posted: 2021-04-29 Discussion: Onsite
BNT162b2 vaccination induces SARS-CoV-2 specific antibody secretion into human milk with minimal transfer of vaccine mRNA
Low, J. M., Gu, Y., Ng, M. S. F., Zubair, A., Lee, L. Y., Ng, Y. P. M., D/O Shunmuganathan, B., Niu, Y., Gupta, R., Tambyah, P. A., Macary, P. A., Wang, L. W., Zhong, Y.
10.1101/2021.04.27.21256151 — Posted: 2021-04-29
Possible link between higher transmissibility of B.1.617 and B.1.1.7 variants of SARS-CoV-2 and increased structural stability of its spike protein and hACE2 affinity
Kumar, V., Singh, J., Hasnain, S. E., Sundar, D.
10.1101/2021.04.29.441933 — Posted: 2021-04-29
Molecular interactions of the M and E integral membrane proteins of SARS-CoV-2
Monje-Galvan, V., Voth, G. A.
10.1101/2021.04.29.442018 — Posted: 2021-04-29
The natural stilbenoid (-)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7 and B.1.351 variants
Tietjen, I., Cassel, J., Register, E. T., Zhou, X. Y., Messick, T. E., Keeney, F., Lu, L. D., Beattie, K. D., Rali, T., Ertl, H. C., Salvino, J. M., Davis, R. A., Montaner, L. J.
10.1101/2021.04.29.442010 — Posted: 2021-04-29
Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany, 2020
Yi, B., Poetsch, A. R., Stadtmueller, M., Rost, F., Winkler, S., Dalpke, A. H.
10.1101/2021.04.29.441906 — Posted: 2021-04-29
Protracted yet coordinated differentiation of long-lived SARS-CoV-2-specific CD8+ T cells during COVID-19 convalescence
Ma, T., Ryu, H., McGregor, M., Babcock, B., Neidleman, J., Xie, G., George, A. F., Frouard, J., Murray, V., Gill, G., Ghosn, E., Newell, E., Lee, S., Roan, N.
10.1101/2021.04.28.441880 — Posted: 2021-04-29 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).